Soluble NKG2D ligand expression associates with smoking, presence of COPD, and presence of lung cancer: The "EMICON" study Source: Annual Congress 2010 - Lung morbidity on exposure to various agents Year: 2010
Increased proportion of Fas positive T-cells in never smoking patients with COPD Source: Annual Congress 2008 - Basic science in asthma and COPD II Year: 2008
IL32 expression in induced sputum of COPD subjects Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013
LSC 2011 Abstract: BAFF in the interaction between T regulatory and B cells in COPD Source: Annual Congress 2011 - COPD: human studies Year: 2011
COPD in northern Sweden 1994-2009: Less under-diagnosis and altered risk factor pattern Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016
LSC 2010 Abstract: Possible effect of GSTM1 and GSTT1 polymorphisms on the risk for development of COPD and total antioxidant plasma capacity Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases Year: 2010
Late Breaking Abstract: FAM13A gene confers reduced risk of COPD and lung cancer in current and former smokers Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010
TNF promoter polymorphisms are associated with susceptibility and increased severity in secondary to tobacco and biomass smoke COPD in Mexican population Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015
Relationship between the influence of exposure to tobacco smoke and max-IMT, ABI, ratio of EPA / AA in COPD patients Source: Annual Congress 2013 –COPD and tobacco management Year: 2013
Novel genes associated with the level of FEV1 in never-smokers in the context of occupational exposure Source: International Congress 2015 – Genetics, genomics and exposures in asthma and COPD Year: 2015
LSC 2011 Abstract: Association of IL-9 and IL-4R genes and their phenotypes among Sudanese with asthma Source: Annual Congress 2011 - Genetics of airway diseases and treatment Year: 2011
LSC 2010 Abstract: Increase in serum and sputum perforin expression in persistent asthma: Preliminary results Source: Annual Congress 2010 - COPD and asthma: models and human studies Year: 2010
Increased expression of a proliferation-inducing ligand (APRIL) in lung leukocytes and alveolar epithelial cells in COPD patients with non small cell lung cancer: A possible link between COPD and lung cancer? Source: International Congress 2016 – Mechanisms of disease Year: 2016
Smoking, genotype and gene expression levels in COPD Source: International Congress 2014 – Personalised exposure and gene environment interactions in chronic airway disease: the exposome and epigenome Year: 2014
Risk of COPD in smokers with low transfer factor Source: Eur Respir J 2016; 47:1885-1886 Year: 2016
Lung cancer gene associated with COPD: triple whammy or possible confounding effect? Source: Eur Respir J 2008; 32: 1158-1164 Year: 2008
-82 A>G promoter polymorphism in the gene of human macrophage elastase (MMP-12) as a risk factor for COPD and bronchial asthma Source: International Congress 2014 – Basic and translational research in asthma and COPD Year: 2014
LSC 2010 Abstract: TNFα promoter polymorphism is associated with increased local production and enhanced downstream inflammation in COPD Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases Year: 2010
Epidermal growth factor (EGF) and its receptors (ERBBs) in smokers with and without COPD: An index of epithelial repair imbalance? Source: Annual Congress 2012 - The smoking gun in COPD biology Year: 2012
Platelet activating factor receptor (PAFr) expression is increased in airways of COPD patients but is not attenuated by inhaled corticosteroid (ICS) Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013